SOLUPORE
LIVE

Serial Number

88509550

Owner

AVECTAS LIMITED

Attorney

Susan Neuberger Weller

Filing Date

Jul 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SOLUPORE Trademark

Serial Number: 88509550 • Registration: 6208574

SOLUPORE is a trademark filed by AVECTAS LIMITED on July 11, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AVECTAS LIMITED (6 trademarks)

34 FITZWILLIAM SQUARE
SOUTH DUBLIN 2 , IE

Entity Type: 99

Trademark Details

Filing Date

July 11, 2019

Registration Date

December 1, 2020

Published for Opposition

September 15, 2020

Goods & Services

Surgical apparatus and instruments, medical apparatus and instruments for the modification of cells for near-patient use; medical apparatus and instruments for the modification of cells for near-patient use; measuring apparatus and instruments for bioassay techniques for medical purposes; parts and fittings for the aforesaid goods

stem cells for research purposes

Pharmaceutical preparations for the treatment of cancer, autoimmune disease, rare diseases, viruses, and for use in cell transplantation and engineered cells; stem cells for medical purposes; living cells for medical use

Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells for the development of cell and gene therapy products; probes for scientific purposes; bioassay apparatus including immune panels; measuring apparatus and instruments, namely, ex-vivo assays for characterization of engineering cells or viruses, other than medical; parts and fittings for the aforesaid goods

Scientific and technological services, namely, research and design in the field of process development services for cell and gene therapy products; industrial analysis and research services in the field of cell and gene therapy, and drug delivery; medical, scientific and pharmaceutical research and development, and clinical testing, in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services in the fields of biotechnology, pharmaceutical research, laboratory testing, pharmacogenetics, clinical trials, development and genetic science

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 20, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 20, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 15, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 10, 2020 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 27, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 21, 2020 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 1, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 1, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 1, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 1, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2020 CRFA
ASSIGNED TO LIE
Apr 9, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 1, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 1, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 1, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2019 NWOS
NEW APPLICATION ENTERED
Jul 15, 2019 NWAP